Drug recall · March 15, 2023
Heparin Sodium recall
Why: Subpotent Drug: low Anti-Factor IIa potency.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Heparin Sodium, 25,000USP units per 250 mL, (100 USP units per mL) in 5% Dextrose Injection, 250 mL Excel Container, B.Braun Medical Inc, Bethlehem, PA. 18018-3524 USA. NDC 0264-9587-20.
- Lots / codes
Lot J2C017; Expiration: 9/30/2023.
- Quantity
- 30672
- Company
- B. Braun Medical Inc, Irvine, CA
- Distribution
- Nationwide in the USA
- Initiated
- March 1, 2023
- Classified
- March 6, 2023
- Reported
- March 15, 2023
- Ended
- March 13, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Heparin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.